[細胞・遺伝子治療] Lonzaが 世界最大の再生医療等製品の製造施設を米国に開設（テキサス洲ヒューストン、パーランド）

・First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases
・With 300,000 square feet (27,870 square meters), it is the largest dedicated cell-and-gene therapy manufacturing facility in the world
・Facility to reach 200 full-time staff by end of 2018 and continue to recruit high-value positions as market demand increases
（リンク先より全文をご覧頂けます）

• リリース情報を見る
• リリース元を見る